Education
About Us
Working with TipRanks
Follow Us
Accuray Incorporated (ARAY)
:ARAY
ARAY Stock Chart & Stats
$1.17
-$0.07(-3.20%)
At close: 4:00 PM EST
$1.17
-$0.07(-3.20%)
Day’s Range― - ―
52-Week Range$0.91 - $2.95
Previous CloseN/A
Volume138.54K
Average Volume (3M)1.10M
Market Cap
$119.01M
Enterprise Value$313.84M
Total Cash (Recent Filing)$63.92M
Total Debt (Recent Filing)$179.11M
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Feb 04, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding113,341,130
10 Day Avg. Volume1,302,685
30 Day Avg. Volume1,098,118
Financial Highlights & Ratios
PEG Ratio0.98
Price to Book (P/B)1.73
Price to Sales (P/S)0.31
P/FCF Ratio-24.86
Enterprise Value/Market Cap2.64
Enterprise Value/Revenue0.70
Enterprise Value/Gross Profit2.26
Enterprise Value/Ebitda35.37
Forecast
1Y Price Target
$4.00Price Target Upside241.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt ManagementThe refinancing agreement addresses investor concerns about near-term debt maturity while preserving a healthy balance sheet.
Market OperationsThere haven't been any order cancellations in China.
Bears Say
Financial CostsThe share dilution and potentially higher interest expense are acknowledged as drawbacks.
Stock PerformanceThe price target has been trimmed from $5 to $4.
Accuray News
ARAY FAQ
What was Accuray Incorporated’s price range in the past 12 months?
Accuray Incorporated lowest stock price was $0.91 and its highest was $2.95 in the past 12 months.
What is Accuray Incorporated’s market cap?
Accuray Incorporated’s market cap is $119.01M.
When is Accuray Incorporated’s upcoming earnings report date?
Accuray Incorporated’s upcoming earnings report date is Feb 04, 2026 which is in 72 days.
How were Accuray Incorporated’s earnings last quarter?
Accuray Incorporated released its earnings results on Nov 05, 2025. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.047 by -$0.133.
Is Accuray Incorporated overvalued?
According to Wall Street analysts Accuray Incorporated’s price is currently Undervalued.
Does Accuray Incorporated pay dividends?
Accuray Incorporated does not currently pay dividends.
What is Accuray Incorporated’s EPS estimate?
Accuray Incorporated’s EPS estimate is -0.12.
How many shares outstanding does Accuray Incorporated have?
Accuray Incorporated has 113,341,130 shares outstanding.
What happened to Accuray Incorporated’s price movement after its last earnings report?
Accuray Incorporated reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.047. Following the earnings report the stock price went down -15.862%.
Which hedge fund is a major shareholder of Accuray Incorporated?
Currently, no hedge funds are holding shares in ARAY
Accuray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (241.88% Upside)
$4.00 (241.88% Upside)
Blogger Sentiment
Bullish
ARAY Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 127.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.44%
12-Months-Change
Fundamentals
Return on Equity
-36.07%
Trailing 12-Months
Asset Growth
-3.44%
Trailing 12-Months
Company Description
Accuray Incorporated
Accuray Incorporated is a global radiation oncology company that specializes in the development of advanced treatment solutions for cancer. Headquartered in Sunnyvale, California, Accuray focuses on innovative technologies that enhance the precision of radiation therapy, primarily through its flagship products, the CyberKnife and TomoTherapy systems. These systems are designed to deliver targeted radiation with high accuracy, thereby minimizing damage to surrounding healthy tissues and improving patient outcomes. Accuray operates within the healthcare sector, specifically addressing the needs of cancer treatment centers and hospitals worldwide.
ARAY Company Deck
ARAY Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Accuray. The company highlighted strong interest and growth in their service segment and new product launches, but faced significant challenges with declining revenue, lower product sales, and increased operating losses. The company's transformation efforts and strategic partnerships show potential for future growth, but current financial metrics indicate concerns.View all ARAY earnings summariesARAY Stock 12 Month Forecast
Average Price Target
$4.00
▲(241.88% Upside)
Technical Analysis
Electromed
―
Inogen
―
LENSAR
―
TriSalus Life Sciences
―
Anteris Technologies Global Corp.
―
Ownership Overview
4.23% Insiders
12.57% Mutual Funds
27.77% Other Institutional Investors
46.84% Public Companies and
Individual Investors